Adeno-associated virus may play a protective role against human papillomavirus-induced cervical lesions independent of HIV serostatus

International Journal of STD and AIDS

Volumn 23, Issue 4, 2012, Pages 258-261

  Bueno de Freitas, L ^a   Tonani de Mattos, A ^a   Lima, B M C ^a   Miranda, A E ^a   Spano, L C ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

AAV; Adeno associated virus; Brazil; Cervical intraepithelial neoplasia; HIV AIDS; HPV; Human papillomavirus

Indexed keywords

VIRUS DNA;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS INFECTION; ADULT; ARTICLE; BRAZIL; CONDYLOMA ACUMINATUM; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MIXED INFECTION; PARVOVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SQUAMOUS CELL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS LOAD; WART VIRUS;

ADOLESCENT; ADULT; BRAZIL; CERVIX UTERI; DEPENDOVIRUS; DNA, VIRAL; FEMALE; GENOTYPE; HIV INFECTIONS; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PARVOVIRIDAE INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; YOUNG ADULT;

EID: 84862297193     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2009.009150     Document Type: Article

References (47)

1. Blacklow NR, Hoggan MD, Rowe WP. Isolation of adeno-associated viruses from man. Proc Natl Acad Sci USA 1967;58:1410-15
2. Parks WP, Boucher DW, Melnick JL, Taber LH, Yow MD. Seroepidemiological and ecological studies of the adenovirus-associated satellite viruses. Infect Immun 1970;2:716-22
3. Bantel-Schaal U, zur Hausen H. Characterization of the DNA of a defective human parvovirus isolated from a genital site. Virology 1984;134:52-63
4. Rutledge EA, Halbert CL, Russell DW. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J Virol 1998;72:309-19
5. Mizukami H, Ozawa K. Utility of AAV vectors derived from novel serotypes. Yakugaku Zasshi 2006;126:1021-28
6. Schmidt M, Voutetakis A, Afione S, Zheng C, Mandikian D, Chiorini JA. Adeno-associated virus type 12 (AAV12): a novel AAV serotype with sialic acid- and heparan sulfate proteoglycan-independent transduction activity. J Virol 2008;82:1399-406
7. Grossman Z, Mendelson E, Brok-Simoni F, et al. Detection of adeno-associated virus type 2 in human peripheral blood cells. J Gen Virol 1992;73:961-66
8. Tobiasch E, Rabreau M, Geletneky K, Larue-Charlus S, Severin F, Becker N. Detection of adeno-associated virus DNA in human genital tissue and in material from spontaneous abortion. J Med Virol 1994;44:215-22
9. Malhomme O, Dutheil N, Rabreau M, Armbruster-Moraes E, Schlehofer JR, Dupressoir T. Human genital tissues containing DNA of adeno-associated virus lack DNA sequences of the helper viruses adenovirus, herpes simplex virus or cytomegalovirus but frequently contain human papillomavirus DNA. J Gen Virol 1997;78:1957-62
10. Walz CM, Deprez A, Dupressoir T, Dürst M, Rabreau M, Schlehofer JR. Interaction of human papillomavirus type 16 and adeno-associated virus type 2 co-infecting human cervical epithelium. J Gen Virol 1997;78:1441-52
11. Rohde V, Erles K, Sattler HP, Derouet H, Wullich B, Schlehofer JR. Detection of adeno-associated virus in human semen: does viral infection play a role in the pathogenesis of male infertility? Fertil Steril 1999;72:814-16
12. Erles K, Rohde V, Thaele M, Roth S, Edler L, Schlehofer JR. DNA of adeno-associated virus (AAV) in testicular tissue and in abnormal semen samples. Hum Reprod 2001;16:2333-37
13. Gao G, Vandenberghe LH, Alvira MR, et al. Clades of adeno-associated viruses are widely disseminated in human tissues. J Virol 2004;78:6381-88
14. Tobiasch F, Burguete T, Klein-Bauernschmitt P, Heilbronn R, Schlehofer JR. Discrimination between different types of human adeno-associated viruses in clinical samples by PCR. J Virol Methods 1998;71:17-25
15. Erles K, Sebokova P, Schlehofer JR. Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV). J Med Virol 1999;59:406-11
16. Berns K, Parrish CR. Parvoviridae. In: Knipe DM, Howley PM, Griffin DE, et al. eds. Fields Virology. 5th edn. Philadelphia: Lippincott Williams &Wilkins, 2007:2437-77
17. Thomson BJ, Weindler FW, Gray D, Schwaab V, Heilbronn R. Human herpesvirus 6 (HHV-6) is a helper virus for adeno-associated virus type 2 (AAV-2) and the AAV-2 rep gene homologue in HHV-6 can mediate AAV-2 DNA replication and regulate gene expression. Virology 1994;204:304-11
18. Grce M, Husnjak K, Matovina M, et al. Human papillomavirus, cytomegalovirus, and adeno-associated virus infections in pregnant and nonpregnant women with cervical intraepithelial neoplasia. J Clin Microb 2004;42:1341-44
19. Hermonat PL. Adeno-associated virus inhibits human papillomavirus type 16: a viral interaction implicated in cervical cancer. Can Res 1994;54:2278-81
20. Meyers C, Alam S, Mane M, Hermonat PL. Altered biology of adeno-associated virus type 2 and human papillomavirus during dual infection of natural host tissue. Virology 2001;287:30-39
21. Agrawal N, Mane M, Chiriva-Internati M, Roman JJ, Hermonat PL. Temporal acceleration of the human papillomavirus life cycle by adeno-associated virus (AAV) type 2 superinfection in natural host tissue. Virology 2002;297:203-10
22. Walz CM, Correa-Ochoa M, Mü ller M, Schlehofer JR. Adenoassociated virus type 2-induced inhibition of the human papillomavirus type 18 promoter in transgenic mice. Virology 2002;293:172-81
23. Hankins C, Coutlée F, Apointe N, et al. Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. CMAJ 1999;160:185-91
24. Weissenborn SJ, Funke AM, Hellmich M, et al. Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated. J Clin Microbiol 2003;41:2763-67
25. Nicol AF, Fernandes ATG, Bonecini-Almeida MG. Immune response in cervical dysplasia induced by human papillomavirus: the influence of human immunodeficiency virus-1 co-infection - Review. Mem Inst Oswaldo Cruz 2005;100:1-12
26. Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988;239:487-91
27. Oliveira LHS, Rodrigues EVM, Lopes APTS, Fernandes AP, Cavalcanti SMB. HPV 16 detections in cervical lesions, physical state of viral DNA and changes in p53 gene. São Paulo Med J 2003;121:67-71
28. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 1989;7:209-14
29. Hermonat PL. Inhibition of bovine papillomavirus plasmid DNA replication by adeno-associated virus. Virology 1992;189:329-33
30. Hermonat PL, Plott RT, Santin AD, Parham GP, Flick JT. Adeno-associated virus Rep 78 inhibits oncogenic transformation of primary human keratinocytes by a human papillomavirus type 16-ras chimeric. Gynec Oncol 1997;66:487-94
31. Laga M, Icenogle JP, Marselha R, et al. Genital papillomavirus infection and cervical dysplasia - opportunistic complications of HIV infection. Int J Cancer 1992;50:45-48
32. La Ruche G, You B, Mensah-Ado I, et al. Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women. Int J Cancer 1998;76:480-86
33. Ellerbrock TV, Chiasson MA, Bush TJ, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000;283:1031-37
34. Hillemanns P, Ellerbrock TV, McPhillips S, et al. Prevalence of anal human papillomavirus infection and anal cytologic abnormalities in HIV-seropositive women. AIDS 1996;10:1641-47
35. Chiasson MA, Ellerbrock TV, Bush TJ, Sun XW, Wright TC Jr. Increased prevalence of vulvovaginal condyloma and vulvar intraepithelial neoplasia inwomen infected with the human immunodeficiency virus. Obstet Gynecol 1997;89:690-94
36. Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC Jr. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997;337:1343-49
37. Han L, Parmley TH, Keith S, Kozlowski KJ, Smith LJ, Hermonat PL. High prevalence of adeno-associated virus (AAV) type 2 rep DNA in cervical materials: AAV may be sexually transmitted. Virus Genes 1996;12:47-52
38. Hyun-Sun J, Heung-Jae C, Byung-Hun K, et al. Correlation of human papillomavirus and adeno-associated virus 2 infection in cytology with Korean women. Int J Gynecol Cancer 2006;16:604-09
39. Cheung AK, Hoggan MD, Hauswirth WW, Berns KI. Integration of adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells. J Virol 1980;33:739-48
40. Tratschin JD, Miller IL, Smith MG, Carter BJ. An adeno-associated virus vector for high frequency integration expression and rescue of genes in mammalian cells. Mol Cell Biol 1986;5:3251-60
41. Hermonat PL, Meyers C, Groesbeck PP, Santin AD. Inhibition/stimulation of bovine papillomavirus by adeno-associated virus is time as well as multiplicity dependent. Virology 1998;247:240-50
42. Coker AL, Russell RB, Bond SM, et al. Adeno-associated virus is associated with a lower risk of high-grade cervical neoplasia. Exp Mol Pathol 2001;70:83-89
43. Smith J, Herrero R, Erles K, et al. Adeno-associated virus seropositivity and HPV-induced cervical cancer in Spain and Colombia. Int J Cancer 2001;94:520-26
44. Agorastos T, Chrisafi S, Lambropoulos AF, et al. Adeno-associated virus infection and cervical neoplasia: is there a protective role against human papillomavirus-related carcinogenesis? Eur J Cancer Prev 2008;17:364-68
45. Strickler HD, Viscidi R, Escoffery C, et al. Adeno-associated virus and development of cervical neoplasia. J Med. Virol 1999;59:60-65
46. Odunsi KO, van Ee CC, Ganesan TS, Shelling AN. Evaluation of the possible protective role of adeno-associated virus type 2 infection in HPV-associated premalignant disease of the cervix. Gynecol Oncol 2000;78:342-45
47. Ahn WS, Bae SM, Chung JE, et al. Evaluation of adenoassociated virus 2 and human papilloma virus 16 and 18 infection in cervical cancer biopsies. Gynec Oncol 2003;89:105-11